Archive | Resident Company News



Telling the story of how healthcare quality can help build and retain a strong workforce while better connecting young tech-based businesses with the state’s leading healthcare providers are among the missions of the Wisconsin Healthcare Business Forum. The creation of the Healthcare Business Forum was announced Tuesday by Eric Borgerding, president and chief executive officer […]

Continue Reading

Madison biotech companies snap up millions in funding from investors

FluGen Inc., a Madison-based firm (And URP tenant) developing a universal flu vaccine, raised $5.58 million in funding through 36 investors, according to the filing. FluGen, which already has investments from Madison’s Venture Investors, the state’s largest venture capital fund, recently shared data from its first test on humans at the annual ID Week conference in San Francisco. […]

Continue Reading

Emerging firms will pitch over two days at 2018 Wisconsin Early Stage Symposium

Forty young companies will pitch to potential investors and others throughout the course of the Nov. 7-8 Wisconsin Early Stage Symposium at Madison’s Monona Terrace Convention Center. That includes 24 companies selected by conference organizers to present Nov. 7 during the Tech Council Investor Networks tracks and 16 more picked for the fast-moving Elevator Pitch […]

Continue Reading

Cologuard® Revenue Increased 63 Percent To $118 Million, And Cologuard Test Volume Grew 49 Percent To 241,000 During Third Quarter

– Demand accelerated from healthcare providers as more than 11,000 ordered their initial Cologuard test during the third quarter, and nearly 132,000 have ordered since the test was launched – Gross margin increased 320 basis points to 75 percent – Exact Sciences now has in-network contracts with all five top commercial health plans, increasing patient […]

Continue Reading

Invenra, Madison Firm Developing Therapeutic Antibodies, Adds $7.1M

Xconomy Wisconsin — Invenra, a Madison, WI-based startup that develops therapeutic antibodies for pharmaceutical companies and other clients, has raised more than $7.1 million from investors, according to a regulatory filing. Twenty-three investors participated in the equity funding round, according to the filing, which was made public earlier this week. Founded in 2011, Invenra has […]

Continue Reading
Forward BIO Institute

Forward BIO Institute awarded $5 million NIH grant

UW-Madison’s Forward BIO Institute has been awarded $5 million from the National Institutes of Health for tissue manufacturing. The grant was announced yesterday at the Biohealth Summit by Professor Bill Murphy, the institute’s director. “This is a unique public-private collaboration that’s committed to advancing the global biomanufacturing industry,” he said. “We want to train the […]

Continue Reading

Forward BIOLABS to host early stage life sciences startups

The recently announced Forward BIOLABS will serve as a landing place for startups, many of which will come out of UW-Madison research. That’s according to co-founder Jessica Martin Eckerly. She says the nonprofit’s goal is to establish a fully equipped life sciences laboratory for early-stage companies, making it easier for them to bring their ideas […]

Continue Reading

Arrowhead Pharmaceuticals inks $250M deal with Janssen Pharmaceuticals that could grow to $3.7B

Arrowhead Pharmaceuticals says it has reached a licensing and collaboration agreement with Janssen Pharmaceuticals that will bring the company $250 million to start and ultimately could be worth as much as $3.7 billion. Janssen will get the worldwide exclusive license for ARO-HBV, a drug that treats chronic hepatitis B, and an option to collaborate with […]

Continue Reading